> top > docs > PubMed:32822224 > annotations

PubMed:32822224 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

Id Subject Object Predicate Lexical cue
T1 27-38 NCBITaxon:11118 denotes Coronavirus
T2 48-56 SP_7 denotes COVID-19
T3 424-435 NCBITaxon:11118 denotes coronavirus
T4 445-453 SP_7 denotes COVID-19
T5 596-604 SP_7 denotes COVID-19
T6 690-698 SP_7 denotes COVID-19
T7 787-795 SP_7 denotes COVID-19
T8 873-880 UBERON:0000948 denotes cardiac
T9 881-886 UBERON:0002100 denotes torso
T10 967-975 SP_7 denotes COVID-19
T11 1066-1074 SP_7 denotes COVID-19
T12 1171-1186 UBERON:0008946 denotes lung parenchyma
T13 1307-1315 SP_7 denotes COVID-19
T14 1875-1883 SP_7 denotes COVID-19

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 821-825 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T2 881-886 Body_part denotes torso http://purl.org/sig/ont/fma/fma7181
T3 1171-1186 Body_part denotes lung parenchyma http://purl.org/sig/ont/fma/fma27360

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 943-963 Body_part denotes morphologic features http://purl.obolibrary.org/obo/UBERON_0034768
T2 1171-1186 Body_part denotes lung parenchyma http://purl.obolibrary.org/obo/UBERON_0008946
T3 1171-1175 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T4 1176-1186 Body_part denotes parenchyma http://purl.obolibrary.org/obo/UBERON_0000353

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 48-56 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 445-453 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 596-604 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 690-698 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 787-795 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 967-975 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T7 1066-1074 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T8 1307-1315 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 1875-1883 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 59-68 http://purl.obolibrary.org/obo/BFO_0000030 denotes OBJECTIVE
T2 99-100 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T3 706-707 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T4 881-886 http://purl.obolibrary.org/obo/UBERON_0002100 denotes torso
T5 1117-1118 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 1171-1175 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T7 1171-1175 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T8 1367-1368 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 27-46 Disease denotes Coronavirus Disease MESH:D018352
3 48-56 Disease denotes COVID-19 MESH:C000657245
16 278-286 Species denotes patients Tax:9606
17 424-443 Disease denotes coronavirus disease MESH:D018352
18 445-453 Disease denotes COVID-19 MESH:C000657245
19 596-604 Disease denotes COVID-19 MESH:C000657245
20 676-684 Species denotes patients Tax:9606
21 690-698 Disease denotes COVID-19 MESH:C000657245
22 787-795 Disease denotes COVID-19 MESH:C000657245
23 967-989 Disease denotes COVID-19 abnormalities MESH:C000657245
24 1026-1034 Species denotes patients Tax:9606
25 1066-1074 Disease denotes COVID-19 MESH:C000657245
26 1307-1315 Disease denotes COVID-19 MESH:C000657245
27 1875-1883 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-58 Sentence denotes Virtual Imaging Trials for Coronavirus Disease (COVID-19).
T2 59-69 Sentence denotes OBJECTIVE.
T3 70-320 Sentence denotes The virtual imaging trial is a unique framework that can greatly facilitate the assessment and optimization of imaging methods by emulating the imaging experiment using representative computational models of patients and validated imaging simulators.
T4 321-605 Sentence denotes The purpose of this study was to show how virtual imaging trials can be adapted for imaging studies of coronavirus disease (COVID-19), enabling effective assessment and optimization of CT and radiography acquisitions and analysis tools for reliable imaging and management of COVID-19.
T5 606-628 Sentence denotes MATERIALS AND METHODS.
T6 629-812 Sentence denotes We developed the first computational models of patients with COVID-19 and as a proof of principle showed how they can be combined with imaging simulators for COVID-19 imaging studies.
T7 813-938 Sentence denotes For the body habitus of the models, we used the 4D extended cardiac-torso (XCAT) model that was developed at Duke University.
T8 939-1109 Sentence denotes The morphologic features of COVID-19 abnormalities were segmented from 20 CT images of patients who had been confirmed to have COVID-19 and incorporated into XCAT models.
T9 1110-1269 Sentence denotes Within a given disease area, the texture and material of the lung parenchyma in the XCAT were modified to match the properties observed in the clinical images.
T10 1270-1415 Sentence denotes To show the utility, three developed COVID-19 computational phantoms were virtually imaged using a scanner-specific CT and radiography simulator.
T11 1416-1424 Sentence denotes RESULTS.
T12 1425-1512 Sentence denotes Subjectively, the simulated abnormalities were realistic in terms of shape and texture.
T13 1513-1654 Sentence denotes Results showed that the contrast-to-noise ratios in the abnormal regions were 1.6, 3.0, and 3.6 for 5-, 25-, and 50-mAs images, respectively.
T14 1655-1666 Sentence denotes CONCLUSION.
T15 1667-1893 Sentence denotes The developed toolsets in this study provide the foundation for use of virtual imaging trials in effective assessment and optimization of CT and radiography acquisitions and analysis tools to help manage the COVID-19 pandemic.